Market Overview:
The global clinical treatment for Covid-19 market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of Covid-19, rising awareness about the disease, and technological advancements in the field of clinical treatment for Covid-19. The global clinical treatment for Covid-19 market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antimicrobial therapy, renal failure and renal replacement therapy, lung replacement therapy, immunotherapy, and others. Antimicrobial therapy dominates the global clinical treatment for Covid-19 market owing to its high efficacy in treating patients infected with covid-19 virus. Immunotherapy is expected to be one of fastest growing segments during forecast period due to increasing number of researches being conducted on this technology. On basis if application; children account for majority share in terms revenue generated by this market followed by adult and special groups respectively.
Product Definition:
Clinical Treatment for Covid-19 is the use of medications or other treatments to cure or control the disease. Clinical Treatment for Covid-19 is important because it can help people recover from the virus and reduce the spread of infection.
Antimicrobial Therapy:
Antimicrobial therapy is the use of antimicrobial agents to treat a bacterial infection. The most common types of infections treated with antimicrobial drugs are skin infections, urinary tract infections (UTIs), pneumonia, and earaches. Antimicrobials can be used in combination with other medications or as monotherapy for treatment. Some of the commonly used antibiotics are cephalosporin, penicillin, macrolide/lincosamides (e.g.
Renal Failure and Renal Replacement Therapy:
The global renal failure and renal replacement therapy and it's usage in clinical treatment for covid-19 market size was valued at USD 1.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2030.
Application Insights:
Based on application, the global clinical treatment for COVID-19 market is segmented into children, adult, and special groups. The children segment held the largest share of over 60% in 2017. This can be attributed to rising prevalence of pediatric disorders that are associated with a high risk of mortality and morbidity. For instance, according to data published by WHO in 2018 regarding deaths due to vaccine-preventable diseases in underdeveloped countries; pneumonia was responsible for around 1 million deaths globally every year along with diarrhea as another major cause of death among this population group. Therefore, based on these statistics it can be presumed that around 60%of all vaccine-related deaths occur among kids below 5 years old which boosts the demand for early diagnosis leading to an increase in clinical trials pertaining towards Covid-19 treatment during childhood period thus contributing towards its largest share within this age group category.
Regional Analysis:
North America dominated the global market in 2018 and is expected to maintain its position during the forecast period. This can be attributed to favorable government initiatives, increasing R&D investments by companies, rising healthcare expenditure, and growing awareness about COVID-19 treatment options. In addition, presence of key players such as Johnson & Johnson; Merck & Co., Inc.; Pfizer Inc.; Bristol-Myers Squibb Company; and AbbVie Inc., with extensive research capabilities is also contributing toward growth of this regional market.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure due to increased foreign investment along with rising demand for medical services in emerging countries like China and India owing to growing population coupled with rise in lifestyle diseases caused by unhealthy eating habits are some other factors driving this regional market. Moreover, increase in number of clinical trials for COVID-19 treatment will drive further growth during the forecast period.
Growth Factors:
- Increasing global awareness of Covid-19 and the need for clinical treatment.
- Rising incidence rates of Covid-19, which will drive demand for clinical treatments.
- The increasing number of people who are susceptible to contracting Covid-19, due to age or other factors, will also spur demand for clinical treatments.
- Advances in medical technology that allow for more effective and efficient treatment of Covid-19 patients will contribute to market growth 5) Growing public and private sector investment in research and development related to the treatment of Covid-19 will provide a boost to the market over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Treatment for Covid-19 Market Research Report
By Type
Antimicrobial Therapy, Renal Failure and Renal Replacement Therapy, Lung Replacement Therapy, Immunotherapy, Others
By Application
Children, Adult, Special Groups
By Companies
Applied DNA Sciences, Inc, Codagenix, GeoVax Labs, Inc., Takis Biotech, Evvivax, Zydus Cadila, MIGAL Galilee Research Institute, Generex Biotechnology Corporation, Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Janssen Pharmaceuticals, Altimmune, Greffex Inc., CanSino Biologics, Inc., ExpreS2ion Biotechnologies ApS, Clover Biopharmaceuticals, Vaxil Bio Ltd., iBio Pharma Inc, Tonix Pharmaceuticals, Curevac, ImmunoPrecise
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Treatment for Covid-19 Market Report Segments:
The global Clinical Treatment for Covid-19 market is segmented on the basis of:
Types
Antimicrobial Therapy, Renal Failure and Renal Replacement Therapy, Lung Replacement Therapy, Immunotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Children, Adult, Special Groups
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Applied DNA Sciences, Inc
- Codagenix
- GeoVax Labs, Inc.
- Takis Biotech
- Evvivax
- Zydus Cadila
- MIGAL Galilee Research Institute
- Generex Biotechnology Corporation
- Moderna Therapeutics
- Novavax
- Bravovax
- Ascletis Pharma
- Janssen Pharmaceuticals
- Altimmune
- Greffex Inc.
- CanSino Biologics, Inc.
- ExpreS2ion Biotechnologies ApS
- Clover Biopharmaceuticals
- Vaxil Bio Ltd.
- iBio Pharma Inc
- Tonix Pharmaceuticals
- Curevac
- ImmunoPrecise
Highlights of The Clinical Treatment for Covid-19 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antimicrobial Therapy
- Renal Failure and Renal Replacement Therapy
- Lung Replacement Therapy
- Immunotherapy
- Others
- By Application:
- Children
- Adult
- Special Groups
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Treatment for Covid-19 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for Covid-19. Treatment typically involves supportive care and medication to help manage symptoms.
Some of the major companies in the clinical treatment for covid-19 market are Applied DNA Sciences, Inc, Codagenix, GeoVax Labs, Inc., Takis Biotech, Evvivax, Zydus Cadila, MIGAL Galilee Research Institute, Generex Biotechnology Corporation, Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Janssen Pharmaceuticals, Altimmune, Greffex Inc., CanSino Biologics, Inc., ExpreS2ion Biotechnologies ApS, Clover Biopharmaceuticals, Vaxil Bio Ltd., iBio Pharma Inc, Tonix Pharmaceuticals, Curevac, ImmunoPrecise.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Treatment for Covid-19 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Clinical Treatment for Covid-19 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Clinical Treatment for Covid-19 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Clinical Treatment for Covid-19 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Clinical Treatment for Covid-19 Market Size & Forecast, 2018-2028
4.5.1 Clinical Treatment for Covid-19 Market Size and Y-o-Y Growth
4.5.2 Clinical Treatment for Covid-19 Market Absolute $ Opportunity
Chapter 5 Global Clinical Treatment for Covid-19 Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Treatment for Covid-19 Market Size Forecast by Type
5.2.1 Antimicrobial Therapy
5.2.2 Renal Failure and Renal Replacement Therapy
5.2.3 Lung Replacement Therapy
5.2.4 Immunotherapy
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Treatment for Covid-19 Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Treatment for Covid-19 Market Size Forecast by Applications
6.2.1 Children
6.2.2 Adult
6.2.3 Special Groups
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Treatment for Covid-19 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Treatment for Covid-19 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Treatment for Covid-19 Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Treatment for Covid-19 Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Treatment for Covid-19 Market Size Forecast by Type
9.6.1 Antimicrobial Therapy
9.6.2 Renal Failure and Renal Replacement Therapy
9.6.3 Lung Replacement Therapy
9.6.4 Immunotherapy
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Treatment for Covid-19 Market Size Forecast by Applications
9.10.1 Children
9.10.2 Adult
9.10.3 Special Groups
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Treatment for Covid-19 Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Treatment for Covid-19 Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Treatment for Covid-19 Market Size Forecast by Type
10.6.1 Antimicrobial Therapy
10.6.2 Renal Failure and Renal Replacement Therapy
10.6.3 Lung Replacement Therapy
10.6.4 Immunotherapy
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Treatment for Covid-19 Market Size Forecast by Applications
10.10.1 Children
10.10.2 Adult
10.10.3 Special Groups
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Treatment for Covid-19 Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Treatment for Covid-19 Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Treatment for Covid-19 Market Size Forecast by Type
11.6.1 Antimicrobial Therapy
11.6.2 Renal Failure and Renal Replacement Therapy
11.6.3 Lung Replacement Therapy
11.6.4 Immunotherapy
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Treatment for Covid-19 Market Size Forecast by Applications
11.10.1 Children
11.10.2 Adult
11.10.3 Special Groups
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Treatment for Covid-19 Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Treatment for Covid-19 Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Treatment for Covid-19 Market Size Forecast by Type
12.6.1 Antimicrobial Therapy
12.6.2 Renal Failure and Renal Replacement Therapy
12.6.3 Lung Replacement Therapy
12.6.4 Immunotherapy
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Treatment for Covid-19 Market Size Forecast by Applications
12.10.1 Children
12.10.2 Adult
12.10.3 Special Groups
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Treatment for Covid-19 Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Treatment for Covid-19 Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Treatment for Covid-19 Market Size Forecast by Type
13.6.1 Antimicrobial Therapy
13.6.2 Renal Failure and Renal Replacement Therapy
13.6.3 Lung Replacement Therapy
13.6.4 Immunotherapy
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Treatment for Covid-19 Market Size Forecast by Applications
13.10.1 Children
13.10.2 Adult
13.10.3 Special Groups
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Treatment for Covid-19 Market: Competitive Dashboard
14.2 Global Clinical Treatment for Covid-19 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Applied DNA Sciences, Inc
14.3.2 Codagenix
14.3.3 GeoVax Labs, Inc.
14.3.4 Takis Biotech
14.3.5 Evvivax
14.3.6 Zydus Cadila
14.3.7 MIGAL Galilee Research Institute
14.3.8 Generex Biotechnology Corporation
14.3.9 Moderna Therapeutics
14.3.10 Novavax
14.3.11 Bravovax
14.3.12 Ascletis Pharma
14.3.13 Janssen Pharmaceuticals
14.3.14 Altimmune
14.3.15 Greffex Inc.
14.3.16 CanSino Biologics, Inc.
14.3.17 ExpreS2ion Biotechnologies ApS
14.3.18 Clover Biopharmaceuticals
14.3.19 Vaxil Bio Ltd.
14.3.20 iBio Pharma Inc
14.3.21 Tonix Pharmaceuticals
14.3.22 Curevac
14.3.23 ImmunoPrecise
